Novonesis Feed

2025-11-07 16:39:38 Trading by management and close relations of management 412,90 DKK | -0,51% | 273 MDKK

2025-11-07 10:35:12 Major shareholder announcement 412,90 DKK | -0,51% | 273 MDKK

2025-11-06 11:12:17 Novonesis delivered 8% organic sales growth in the first nine months of 2025 415,00 DKK | +6,99% | 454 MDKK

2025-11-06 07:57:00 8% organic sales growth after first nine months. Full-year organic sales growth narrowed upwards. 415,00 DKK | +6,99% | 454 MDKK

2025-11-04 15:11:18 Trading by management and close relations of management 381,90 DKK | -1,42% | 228 MDKK

2025-10-23 13:03:36 Noma and Novonesis partner to scale deliciousness 408,00 DKK | -0,10% | 210 MDKK

2025-10-06 16:00:00 Novonesis Hosts National Flagship Manufacturing Day Event at North America Headquarters 388,00 DKK | -0,79% | 128 MDKK

2025-09-10 14:09:15 Major shareholder announcement 404,70 DKK | -0,54% | 182 MDKK

2025-09-08 08:43:03 Novonesis and Novo Nordisk will explore new solutions to improve metabolic health 405,10 DKK | -1,12% | 125 MDKK

2025-09-02 12:57:37 Trading by management and close relations of management 402,40 DKK | -0,25% | 189 MDKK

2025-08-28 12:20:01 Amendment: Trading by management and close relations of management 411,70 DKK | +2,23% | 394 MDKK

2025-08-28 11:52:08 Trading by management and close relations of management 411,70 DKK | +2,23% | 394 MDKK

2025-08-22 16:43:17 Trading by management and close relations of management 400,90 DKK | +2,79% | 443 MDKK

2025-08-22 12:33:06 Trading by management and close relations of management 400,90 DKK | +2,79% | 443 MDKK

2025-08-21 08:03:57 Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8% 390,00 DKK | -6,97% | 696 MDKK

2025-08-21 07:58:00 Interim report H1 2025 390,00 DKK | -6,97% | 696 MDKK

2025-08-20 19:35:35 2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement 390,00 DKK | -6,97% | 696 MDKK

2025-08-20 17:45:15 2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement 390,00 DKK | -6,97% | 696 MDKK

2025-07-21 11:56:29 Major shareholder announcement 445,60 DKK | -0,96% | 147 MDKK

2025-07-07 08:33:52 Biosolutions could create more than 600,000 jobs and unlock hundreds of billions in growth for Europe 458,90 DKK | +0,39% | 151 MDKK

2025-06-30 18:59:30 Transactions under Novonesis’ share buyback program 455,60 DKK | +0,33% | 343 MDKK

2025-06-23 15:31:43 Transactions under Novonesis’ share buyback program 468,70 DKK | -0,53% | 187 MDKK

2025-06-23 15:14:09 Major shareholder announcement 468,70 DKK | -0,53% | 187 MDKK

2025-06-19 08:58:39 Major shareholder announcement 474,30 DKK | +0,21% | 136 MDKK

2025-06-16 13:37:51 Transactions under Novonesis’ share buyback program 487,00 DKK | +0,31% | 298 MDKK

2025-06-12 12:21:57 Major shareholder announcement 486,90 DKK | -0,08% | 220 MDKK

2025-06-10 17:01:04 Transactions under Novonesis’ share buyback program 487,30 DKK | +0,83% | 238 MDKK

2025-06-10 09:34:25 Trading by management and close relations of management 483,30 DKK | +0,96% | 283 MDKK

2025-06-02 13:05:39 Novonesis completes acquisition of dsm-firmenichs’s share of the Feed Enzyme Alliance 468,00 DKK | +1,34% | 462 MDKK

2025-06-02 11:29:34 Transactions under Novonesis’ share buyback program 468,00 DKK | +1,34% | 462 MDKK

2025-05-26 13:40:15 Transactions under Novonesis’ share buyback program 465,50 DKK | +0,84% | 138 MDKK

2025-05-19 14:00:00 Combining EVP roles of Human Health Biosolutions and Strategy & Integration 452,60 DKK | +0,31% | 149 MDKK

2025-05-19 13:51:07 Transactions under Novonesis’ share buyback program 452,60 DKK | +0,31% | 149 MDKK

2025-05-12 13:43:38 Transactions under Novonesis’ share buyback program 436,40 DKK | -1,82% | 248 MDKK

2025-05-12 13:36:38 Trading by management and close relations of management 436,40 DKK | -1,82% | 248 MDKK

2025-05-08 08:00:17 Novonesis delivered a strong Q1 with 11% organic growth and confirms full-year outlook 444,30 DKK | +4,37% | 529 MDKK

2025-05-08 07:58:00 Interim report Q1 2025 444,30 DKK | +4,37% | 529 MDKK

2025-05-05 15:18:45 Transactions under Novonesis’ share buyback program 433,30 DKK | 0,00% | 149 MDKK

2025-04-28 09:17:09 Transactions under Novonesis’ share buyback program 411,00 DKK | -0,46% | 132 MDKK

2025-04-22 17:00:00 Andrew Taylor joins Novonesis’ Executive Leadership Team 410,90 DKK | +1,43% | 167 MDKK

2025-04-22 14:25:40 Transactions under Novonesis’ share buyback program 405,10 DKK | -1,17% | 121 MDKK

2025-04-14 10:26:10 Transactions under Novonesis’ share buyback program 403,80 DKK | +1,56% | 194 MDKK

2025-04-07 12:29:39 Transactions under Novonesis’ share buyback program 380,20 DKK | -6,90% | 499 MDKK

2025-04-03 17:43:00 Resolutions from the Annual General Meeting 2025 408,40 DKK | -1,26% | 497 MDKK

2025-03-31 11:14:13 Transactions under Novonesis’ share buyback program 401,00 DKK | -0,55% | 254 MDKK

2025-03-26 17:05:51 Trading by management and close relations of management 399,80 DKK | +0,55% | 190 MDKK

2025-03-24 17:00:34 Transactions under Novonesis’ share buyback program 400,60 DKK | +0,75% | 173 MDKK

2025-03-17 11:36:36 Transactions under Novonesis’ share buyback program 408,10 DKK | -1,57% | 211 MDKK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Novonesis

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden